Immunonutrition to reduce mouth sores after cancer treatment
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial studies whether special nutritional supplements (immunonutrients) can reduce painful mouth sores (oral mucositis) in people with nasopharyngeal cancer after chemoradiotherapy. If you qualify, you’ll be followed with visits and lab tests to see if the supplements improve comfort and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–70 years old (and able to be in the study if you’re a man, or a non-pregnant woman).
- You have non-keratinizing nasopharyngeal cancer, diagnosed and staged as stage III to IVA.
- Your overall health is fairly good (ECOG 0–1).
- Your blood, liver, kidney, and blood-clotting test results are within allowed ranges.
- You must be newly diagnosed and starting the study after planned chemoradiotherapy, with no prior radiation or anti-cancer treatments.
- You currently do not have mouth sores, are not malnourished, and can eat the required soft foods by mouth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of a new immunotherapy (QL1706) plus standard chemoradiation for people with advanced nasopharyngeal cancer that hasn't spread to distant organs. The goal is to see if adding this drug helps control the cancer better than standard treatment alone.
This trial tests if special nutritional management during concurrent chemoradiotherapy can improve outcomes for people with nasopharyngeal cancer. If you are getting both chemotherapy and radiation as your main treatment, this study may help you maintain better nutrition.
This trial tests if an inhaled medication called Sapylin can prevent or reduce severe mouth sores caused by chemoradiation, compared to a standard steroid inhalation. It is for people with advanced nasopharyngeal cancer who have not yet started treatment.
This trial tests whether a special protein supplement can help prevent or reduce painful mouth sores (oral mucositis) that often develop when people receive radiation therapy for head and neck cancer. Researchers believe extra protein may help the mouth heal better during treatment.
This study tests whether special nutritional support (called immunonutrition) helps patients with head and neck, lung, or rectal cancer who are receiving chemotherapy, radiation, or immunotherapy. The goal is to see if it improves how well treatment works and how you feel during and after cancer care.
This study tests if a mouth rinse with GM-CSF (a protein that helps healing) can prevent mouth sores caused by radiation therapy for nasopharyngeal carcinoma. If you are about to start radiation, this may help reduce pain and trouble eating.
Hear when a new Locally Advanced Nasopharyngeal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.